Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

Subjects:

The percentage of received patients who migrated for primary knee arthroplasty in different provinces. by Fanqiang Meng (4786071)

Subjects:

Flowchart of analysis. by Fanqiang Meng (4786071)

Subjects:

Patient migration rates for primary knee arthroplasty from 2013 to 2018. by Fanqiang Meng (4786071)

Subjects:

Comparison of postoperative outcomes and financial burden between migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Subjects:

Sankey diagram of patient migration for primary knee arthroplasty in China. by Fanqiang Meng (4786071)

Subjects:

Demographics of patients who underwent primary knee arthroplasty during 2013 to 2018. by Fanqiang Meng (4786071)

Subjects:

Baseline characteristics of propensity score-matched migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Subjects:

The percentage of patients who migrated to outside provinces for primary knee arthroplasty in different provinces. by Fanqiang Meng (4786071)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Significant associations in GWAS. by Dai Nogimura (21445649)

Subjects:

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

Effects of s-ketamine and midazolam on respiratory parameters. by Oscar F. C. van den Bosch (22184246)

Subjects:

Flow chart of the study participants. by Oscar F. C. van den Bosch (22184246)

Subjects: